Figure 2
From: Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extent
Cholesterol and triglyceride analysis of FPLC fractions of serum samples 14 days after viral gene transfer. Western blot analysis for human apoA-I in the HDL fractions is shown below the cholesterol tracing.